PI
AGN.PRA

Putnam Investments’s Allergan plc AGN.PRA Stock Holding History

Putnam Investments’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-41,814
Closed -$24.4M – 1246
2017
Q4 		$24.4M Sell
41,814
-8,585
-17% -$5.54M 0.05% 238
2017
Q3 		$36.9M Buy
50,399
+30
+0.1% +$24.9K 0.09% 193
2017
Q2 		$43.7M Sell
50,369
-13,957
-22% -$11.7M 0.1% 178
2017
Q1 		$54.7M Sell
64,326
-22,501
-26% -$18.6M 0.13% 163
2016
Q4 		$46.5M Buy
86,827
+6,001
+7% +$4.54M 0.11% 184
2016
Q3 		$67.4M Buy
80,826
+1,128
+1% +$975K 0.16% 146
2016
Q2 		$67.5M Buy
79,698
+5,432
+7% +$4.54M 0.16% 153
2016
Q1 		$69.4M Sell
74,266
-46,916
-39% -$44.9M 0.16% 142
2015
Q4 		$126M Sell
121,182
-10,019
-8% -$10.1M 0.29% 80
2015
Q3 		$125M Sell
131,201
-1,151
-0.9% -$1.2M 0.28% 82
2015
Q2 		$139M Buy
+132,352
New +$139M 0.28% 77

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Putnam Investments's AGN.PRA Position: Q1 2018 in Review

Putnam Investments sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 41,814 shares — an estimated $24.4M sold.

Putnam Investments first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $139M in Q2 2015. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Putnam Investments reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Putnam Investments sold 41,814 Allergan plc shares in Q1 2018, an estimated $24.4M.
  • Putnam Investments first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Putnam Investments's Allergan plc position peaked at $139M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Putnam Investments's 13F filing for Q1 2018, filed 15 May 2018.